| | | | | | | | San Francisco-based Cellares is promising to deliver in an area where traditional CDMOs have fallen short by taking an Industry 4.0 approach to commercializing today’s most cutting-edge medicines. The company’s core technology, known as the Cell Shuttle, automates the entire cell therapy manufacturing process from start to finish. |
|
|
|
| |
| | |
|
|
| | | | | The decision comes after Relyvrio failed to show benefit in a phase 3 trial. |
|
|
| A decade after its European launch, Zevtera is now approved for three indications in the U.S. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Advanced chemical indicators give you the peace of mind that comes from reliable insights into your supply chains. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
